Literature DB >> 613946

Aflatoxin and encephalopathy with fatty degeneration of viscera (Reye).

I Dvorácková, V Kusák, D Veselý, J Veselá, P Nesnídal.   

Abstract

In the past 5 years we have observed 27 children at the age from 3 days to 8 years who died on the encephalic syndrome with fatty degeneration of the viscera (Reye). According to the morphological changes in the liver and to the clinical course, we have divided our cases into 3 groups. In the first group there were 20 children who died within 2-10 days after the first symptoms of the disease appeared. In their liver diffuse fatty degeneration was found. In the second group there were 3 children who died within 1-2 months after the acute onset of the disease. In their liver fibrosis with bile duct proliferation and steatosis were found. In the third group there were 4 children who died within 2-4 months after the first symptoms. Their liver showed cirrhosis. The bacteriological and virological investigations in all cases were negative, but in the most of them direct contacts with viral infections were proved. In the liver specimens of the children in all 3 groups the presence of aflatoxin B1 chromatographically and spectrophotometrically was found. The source of the intoxication in 5 cases was aflatoxin contaminated milk food. Our observations of 2 - 3 - days old newborns with the morphological changes similar to that of Reye's syndrome seems to support our hypothesis about the possibility of the intrauterine intoxication. We suggest that aflatoxin represents an important factor in the etiology of this syndrome and a high risk for human health.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 613946

Source DB:  PubMed          Journal:  Ann Nutr Aliment        ISSN: 0003-4037


  5 in total

1.  Aflatoxin excretion in children with kwashiorkor or marasmic kwashiorkor--a clinical investigation.

Authors:  H R de Vries; S M Maxwell; R G Hendrickse
Journal:  Mycopathologia       Date:  1990-04       Impact factor: 2.574

2.  Use of chick embryo in screening for toxin-producing fungi.

Authors:  D Veselý; D Veselá; R Jelínek
Journal:  Mycopathologia       Date:  1984-12-30       Impact factor: 2.574

3.  Evidence of aflatoxin B1 in two cases of lung cancer in man.

Authors:  I Dvorackova; C Stora; N Ayraud
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

4.  The effect of aflatoxin B1 exposure on serotonin metabolism: response to a tryptophan load.

Authors:  T D Kimbrough; G C Llewellyn; L B Weekley
Journal:  Metab Brain Dis       Date:  1992-12       Impact factor: 3.584

5.  Does aflatoxin exposure in the United Kingdom constitute a cancer risk?

Authors:  J C Harrison; M Carvajal; R C Garner
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.